Drugs Made In America Acquisition (DMIIU) Enterprise Value (2025 - 2026)
Drugs Made In America Acquisition's Enterprise Value was $640.65 million in Q2 2026.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIU) Enterprise Value (2025 - 2026) Analysis & Trends
On a trailing twelve-month basis, Drugs Made In America Acquisition's Enterprise Value was $640.31 million through Jun 30, 2026; for FY2025, it was $258.45 million.
Peer Set
Peer Comparison
API Access
Drugs Made In America Acquisition Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=DMIIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "DMIIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=DMIIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();